scholarly journals Epidemiological Risk Factors for Acquiring Severe COVID-19: Prospective Cohort Study

2021 ◽  
Vol 36 (5) ◽  
pp. e301-e301
Author(s):  
Salah T. Al Awaidy ◽  
Faryal Khamis ◽  
Ozayr Mahomed ◽  
Ronald Wesonga ◽  
Muna Al Shuabi ◽  
...  

Objectives: We aimed to determine epidemiological risk factors associated with acquiring severe coronavirus disease 2019 (COVID-19) in patients requiring hospitalization. Methods: A prospective cohort study was conducted using a questionnaire comprised of six closed-ended questions to identify potential risk factors for severe COVID-19. Using COVID-19 associated illnesses and complications (pneumonia, acute respiratory distress syndrome, need for mechanical ventilation, acute kidney failure, cardiac failure, and thromboembolic events), we derived an index variable to measure the severity of COVID-19 in patients. Results: We included 143 adult patients with confirmed COVID-19 of whom 62.2% (n = 89) were male and 37.8% (n = 54) were female. The average age of the cohort was 50.6±16.5 years. Our study found that being a female, working at the health care facility, being a healthcare worker, attending a mass gathering within the last 14 days, attending a gathering with 10 persons or less, and being admitted to a hospital were associated with increased risk of developing severe COVID-19. The only risk factor associated with severe COVID-19 was working at a health care facility (odds ratio = 33.42, p =0.029). Conclusions: Intervention directed to control risk factors associated with acquiring severe COVID-19 should be a core priority for all countries, especially among high-risk occupations and workplaces, including working at a health care facility. A risk-based approach to prioritize vaccination among these high-risk individuals should be supported to strengthen the implementation of non-pharmaceutical interventions.

2009 ◽  
Vol 181 (4S) ◽  
pp. 142-142
Author(s):  
Charles R Vincent ◽  
Mary Brown ◽  
Leticia Reyes ◽  
Benjamin K Canales ◽  
Keith Muller ◽  
...  

2018 ◽  
Vol 45 (4) ◽  
pp. 521-528 ◽  
Author(s):  
Akinori Hara ◽  
Takashi Wada ◽  
Ken-ei Sada ◽  
Koichi Amano ◽  
Hiroaki Dobashi ◽  
...  

Objective.The aim was to elucidate the prognosis and risk factors associated with relapse during longterm remission maintenance therapy for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).Methods.Patients with newly diagnosed AAV (n = 156) were registered in the Remission Induction Therapy in Japanese patients with ANCA-associated Vasculitides (RemIT-JAV) study, and among them, 83 patients who achieved remission were enrolled and followed up for 24 additional months in our nationwide, prospective cohort study (Co-RemIT-JAV; registration number UMIN 000006373). Patterns of maintenance therapy, effectiveness, and safety were evaluated from months 25 to 48 after the RemIT-JAV. The primary outcome measure was the rate of relapse. Secondary outcome measures included overall and renal survival, risk factors associated with relapse, and incidence rates of serious infections.Results.The patients comprised 35 men and 48 women aged 65.3 ± 12.6 years. Between months 25 and 48, the survival rate was 95% (79/83). Causes of death included 1 thyroid cancer, 1 infection, and 2 unknown reasons. Four patients had developed endstage renal disease (ESRD) by Month 24; 1 developed ESRD beyond Month 25. The relapse rate was 24% (20/83) from months 25 to 48. Multivariable analysis revealed that oral prednisolone ≤ 2.5 mg/day at Month 24 was a significant risk factor for relapse between months 25 and 48 (HR = 3.1, 95% CI 1.1–8.5).Conclusion.One-quarter of patients with AAV relapsed during maintenance therapy, and relapse was associated with the dose of oral prednisolone 24 months after the initiation of remission induction therapy in Japan.


2013 ◽  
Vol 189 (3) ◽  
pp. 904-910 ◽  
Author(s):  
Charles R. Vincent ◽  
Tami L. Thomas ◽  
Leticia Reyes ◽  
C. LeAnn White ◽  
Benjamin K. Canales ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document